Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

Infection

Volumn 40, Issue 6, 2012, Pages 677-684

  Egli, A ^a,b   Bucher, C ^a   Dumoulin, A ^b   Stern, M ^a   Buser, A ^a   Bubendorf, L ^c   Gregor, M ^d   Servida, P ^e   Sommer, G ^a   Bremerich, J ^a   Gratwohl, A ^a   Khanna, N ^a   Widmer, A F ^a   Battegay, M ^a   Tamm, M ^a   Hirsch, H H ^a,b   Halter, J P ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d Division of Hematology   (Switzerland)

^e EOC Bellinzona   (Switzerland)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Human metapneumovirus; Posttransplant infection; Respiratory virus; Treatment

Indexed keywords

IMMUNOGLOBULIN G; RIBAVIRIN;

ABSENCE OF SIDE EFFECTS; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORONAVIRUS INFECTION; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN METAPNEUMOVIRUS INFECTION; HYPOXEMIA; LOADING DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MALE; MIXED INFECTION; PROSPECTIVE STUDY; RHINOVIRUS INFECTION; TREATMENT DURATION;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METAPNEUMOVIRUS; MIDDLE AGED; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 84872875290     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0279-9     Document Type: Article

References (25)

1. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol. 2008; 143:455-67.
2. Anderson EJ. Viral diagnostics and antiviral therapy in hematopoietic stem cell transplantation. Curr Pharm Des. 2008;14:1997-2010.
3. Ison MG Respiratory viral infections in transplant recipients. Antivir Ther. 2007;12:627-38
4. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719-24.
5. Chatzidimitriou D, Gavriilaki E, Sakellari I, Diza E. Hematopoietic cell transplantation and emerging viral infections. J Med Virol. 2010;82:528-38.
6. Papenburg J, Boivin G. The distinguishing features of human metapneumovirus and respiratory syncytial virus. Rev Med Virol. 2010;20:245-60.
7. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28:479-84.
8. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: singlecenter study and review of the literature. Clin Infect Dis. 2008; 46:402-12.
9. Dumoulin A, Widmer AF, Hirsch HH. Comprehensive diagnostics for respiratory virus infections after transplantation or after potential exposure to swine flu A/H1N1: what else is out there? Transpl Infect Dis. 2009;11:287-9.
10. Reijans M, Dingemans G, Klaassen CH, et al. RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses. J Clin Microbiol. 2008;46:1232-40.
11. Bonney D, Razali H, Turner A, Will A. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. Br J Haematol. 2009;145:667-9.
12. Russmann S, Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem. 2006; 13:3351-7.
13. Campbell AP, Chien JW, Kuypers J, et al. Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. J Infect Dis. 2010;201:404-13.
14. Debur MC, Vidal LR, Stroparo E, et al. Human metapneumovirus infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2010;12:173-9.
15. Oliveira R, Machado A, Tateno A, Boas LV, Pannuti C, Machado C. Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years. Bone Marrow Transplant. 2008;42:265-9.
16. Cane PA, van den Hoogen BG, Chakrabarti S, Fegan CD, Osterhaus AD. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant. 2003;31:309-10.
17. Englund JA, Boeckh M, Kuypers J, et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med. 2006;144:344-9.
18. Franquet T, Rodríguez S, Martino R, Salinas T, Giménez A, Hidalgo A. Human metapneumovirus infection in hematopoietic stem cell transplant recipients: high-resolution computed tomography findings. J Comput Assist Tomogr. 2005;29:223-7.
19. Huck B, Egger M, Bertz H, et al. Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer. J Clin Microbiol. 2006;44:2300-3.
20. Ison MG, Hayden FG. Viral infections in immunocompromised patients: what's new with respiratory viruses? Curr Opin Infect Dis. 2002;15:355-67.
21. Lacey SF, Diamond DJ, Zaia JA. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants. Biol Blood Marrow Transplant. 2004;10:433-47.
22. Safdar A. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients. Bone Marrow Transplant. 2008;41:707-8.
23. Fischer SA. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation. 2008;86:1327-39.
24. Hamelin ME, Prince GA, Boivin G. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother. 2006;50: 774-7.
25. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-56.